Breakdown | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|
Income Statement | |||||
Total Revenue | 130.64B | 115.81B | 105.00B | 96.07B | 82.45B |
Gross Profit | 36.10B | 32.40B | 27.13B | 23.95B | 21.69B |
EBITDA | 18.94B | 16.58B | 12.78B | 11.38B | 9.80B |
Net Income | 12.18B | 12.31B | 8.65B | 8.17B | 6.30B |
Balance Sheet | |||||
Total Assets | 141.78B | 130.53B | 113.00B | 103.70B | 96.91B |
Cash, Cash Equivalents and Short-Term Investments | 53.41B | 54.24B | 46.39B | 44.16B | 39.92B |
Total Debt | 0.00 | 0.00 | 0.00 | 1.00M | 1.00M |
Total Liabilities | 38.27B | 37.71B | 33.09B | 31.79B | 32.21B |
Stockholders Equity | 102.80B | 92.71B | 79.83B | 71.85B | 64.66B |
Cash Flow | |||||
Free Cash Flow | 3.11B | 10.20B | 3.50B | 5.21B | 9.50B |
Operating Cash Flow | 10.38B | 12.58B | 5.51B | 6.57B | 11.18B |
Investing Cash Flow | -9.52B | -2.88B | -2.26B | -1.50B | -1.65B |
Financing Cash Flow | -2.13B | -2.29B | -1.24B | -1.06B | -1.09B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
75 Outperform | ¥83.58B | 13.08 | 5.18% | 2.41% | 1.41% | -37.86% | |
73 Outperform | ¥73.42B | 8.76 | 4.45% | -1.71% | 0.39% | ||
73 Outperform | €7.62T | 20.57 | 9.91% | 1.35% | 4.21% | 33.53% | |
71 Outperform | ¥267.71B | 14.94 | 8.32% | 2.77% | 6.08% | 11.04% | |
70 Outperform | $13.14T | 52.25 | 10.85% | 0.59% | 6.78% | 8.83% | |
68 Neutral | ¥151.36B | 11.94 | 2.06% | 13.93% | -1.88% | ||
63 Neutral | $1.69T | 21.99 | 11.02% | 1.38% | 15.11% | 142.87% |